Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Angina Market From 2025 To 2029?

In recent times, there has been a significant growth in the market size of angina. There is a projected growth from $10.71 billion in 2024 to $11.4 billion in 2025, showcasing a compound annual growth rate (CAGR) of 6.4%. Factors contributing to growth during the historic period include a rise in coronary heart disease occurrence, heightened use of vasodilators, an increased incidence of myocardial ischemia, enhancements in diagnostic abilities, and a surge in the utilization of imaging techniques.

What Is the Projected Market Size of the Angina Market?

The market size for angina is projected to experience robust growth in the upcoming years, estimated to reach $14.44 billion in 2029 with a compound annual growth rate (CAGR) of 6.1%. The projected growth in the forecast period can be connected to the increasing occurrence of chronic angina pectoris, a surge in drug approvals and clinical research, heightened demand for retail pharmacies, growing consciousness about cardiovascular health, and escalating demand for medications. Key trends in the forecast period encompass technological progress in early diagnosis, advancements in procedures like angioplasty and stenting, innovative gene therapy methods, demand for coronary stents, and improvements in the treatment of coronary artery disease.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16337&type=smp

Who are the Major Competitors in the Angina Market Outlook?

Major companies operating in the angina market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., Bayer AG, Sanofi S.A., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott laboratories, GlaxoSmithKline Plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd, Amgen Inc., Dr. Reddy’s Laboratories, ViroMed Co. Ltd., Lee’s Pharmaceutical Holdings, Kuhnil Pharmaceutical, LegoChem Biosciences, Axus Cardium Pharmaceuticals, Juventas Therapeutics, Milestone Pharmaceuticals

What Is Fueling Growth in the Angina Market?

The growth of the angina market going forward is expected to be spurred by the escalating incidences of coronary artery diseases. Coronary artery disease (CAD), also referred to as coronary heart disease (CHD) or ischemic heart disease (IHD), is a condition manifested by the constriction or obstruction of the coronary arteries that facilitate the supply of blood, oxygen, and nutrients to the heart muscle. The upward trend of coronary artery disease (CAD) incidences can be attributed to alterations in lifestyle and environmental and genetic influences. Angina is crucial in pinpointing and grasping the prevalence of coronary artery disease. Its existence necessitates medical assessment and diagnosis, aids in categorizing risk, directs treatment options, and shapes public health policies. For example, data from the American Heart Association in January 2023 showed that the population of adults in the U.S. enduring Coronary artery disease (CAD) escalated from 18.2 million to nearly 19.3 million between 2021 and 2022. Consequently, the surge in coronary artery diseases propels the angina market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=16337&type=smp

Which Angina Market Segments Are Growing the Fastest?

The angina market covered in this report is segmented –

1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types

2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments

3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes

4) By Application: Clinics, Hospitals, Other Applications

Subsegments:

1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina

2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina

3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina

4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease

Which Industry Trends Are Shaping the Future of the Angina Market?

Major players in the angina market are working on the development of ground-breaking medicines like metoprolol tartrate tablets, aimed at offering efficient and specialised treatments for patients suffering from Coronary Artery Disease (CAD) and other related conditions. Metoprolol tartrate tablets are a frequently utilized medication for treating several heart-related conditions, spanning angina (chest pain), hypertension (high blood pressure) and heart failure. To illustrate, in April 2023, the Indian pharmaceutical firm, Zydus, acquired the final endorsement from the US Food and Drug Administration (US-FDA) for the production and distribution of its generic Metoprolol Tartrate Tablets USP, available in dosages of 25 mg, 50 mg, and 100 mg. Metoprolol is a beta-blocker administered to manage various cardiovascular ailments, comprising high blood pressure (hypertension), and chest pain (angina), as well as to enhance the chances of survival following a heart attack.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Which Countries Are Leading the Angina Market?

North America was the largest region in the angina market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16337

This Report Delivers Insight On:

1. How big is the angina market, and how is it changing globally?

2. Who are the major companies in the angina market, and how are they performing?

3. What are the key opportunities and risks in the angina market right now?

4. Which products or customer segments are growing the most in the angina market?

5. What factors are helping or slowing down the growth of the angina market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model